(OR) L’Oreal - Ratings and Ratios
Skincare, Makeup, Haircare, Fragrance, Hygiene
Description: OR L’Oreal
L’Oréal S.A. (ticker OR) is a French multinational that manufactures and sells a broad portfolio of cosmetic and personal-care products for both women and men, operating through four primary divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty.
The company’s brand roster spans mass-market names such as L’Oréal Paris, Garnier, Maybelline New York, and NYX, mid-tier professional lines like L’Oréal Professionnel, Kérastase, and Redken, and luxury offerings including Lancôme, Yves Saint Laurent Beauté, Armani Beauty, and Valentino. This tiered structure allows L’Oréal to capture demand across price points and consumer segments.
Sales are distributed through a mix of hair salons, mass-market retailers, department-store perfumeries, pharmacies, drugstores, medi-spas, travel-retail outlets, and increasingly via e-commerce platforms. Recent data (FY 2023) show total revenue of €38.2 billion, with e-commerce contributing a 15 % year-over-year increase and operating margin expanding to 15.5 % driven by higher-margin luxury sales and cost-efficiency programs. Key sector drivers include rising disposable income in emerging markets, accelerated digital adoption post-COVID-19, and growing consumer preference for “clean” and sustainable beauty products, which L’Oréal is addressing through its “Sharing Beauty With All” sustainability roadmap.
For a deeper quantitative dive into L’Oréal’s valuation sensitivities, the ValueRay platform offers a granular, data-driven model worth exploring.
OR Stock Overview
| Market Cap in USD | 229,916m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
OR Stock Ratings
| Growth Rating | 47.9% |
| Fundamental | 75.9% |
| Dividend Rating | 67.3% |
| Return 12m vs S&P 500 | -6.97% |
| Analyst Rating | - |
OR Dividends
| Dividend Yield 12m | 1.81% |
| Yield on Cost 5y | 2.59% |
| Annual Growth 5y | 14.42% |
| Payout Consistency | 99.9% |
| Payout Ratio | 61.3% |
OR Growth Ratios
| Growth Correlation 3m | -25.3% |
| Growth Correlation 12m | 81.4% |
| Growth Correlation 5y | 49.7% |
| CAGR 5y | 6.22% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.21 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.59 |
| Sharpe Ratio 12m | -0.56 |
| Alpha | -4.77 |
| Beta | 0.852 |
| Volatility | 23.51% |
| Current Volume | 241.2k |
| Average Volume 20d | 298k |
| Stop Loss | 374.7 (-3%) |
| Signal | 0.82 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (11.21b TTM) > 0 and > 6% of Revenue (6% = 4.61b TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 2.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.75% (prev 3.46%; Δ 0.28pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 11.79b > Net Income 11.21b (YES >=105%, WARN >=100%) |
| Net Debt (4.01b) to EBITDA (18.35b) ratio: 0.22 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (535.4m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 73.80% (prev 73.89%; Δ -0.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 144.3% (prev 79.42%; Δ 64.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 27.45 (EBITDA TTM 18.35b / Interest Expense TTM 568.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.91
| (A) 0.05 = (Total Current Assets 18.28b - Total Current Liabilities 15.40b) / Total Assets 54.60b |
| (B) 0.41 = Retained Earnings (Balance) 22.26b / Total Assets 54.60b |
| (C) 0.29 = EBIT TTM 15.59b / Avg Total Assets 53.23b |
| (D) 1.21 = Book Value of Equity 28.23b / Total Liabilities 23.42b |
| Total Rating: 4.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.86
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 4.67% = 2.33 |
| 3. FCF Margin 12.22% = 3.06 |
| 4. Debt/Equity 0.28 = 2.46 |
| 5. Debt/Ebitda 0.22 = 2.46 |
| 6. ROIC - WACC (= 20.34)% = 12.50 |
| 7. RoE 36.45% = 2.50 |
| 8. Rev. Trend -13.75% = -1.03 |
| 9. EPS Trend 11.60% = 0.58 |
What is the price of OR shares?
Over the past week, the price has changed by +2.71%, over one month by +2.39%, over three months by +6.14% and over the past year by +6.83%.
Is L’Oreal a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OR is around 365.21 EUR . This means that OR is currently overvalued and has a potential downside of -5.47%.
Is OR a buy, sell or hold?
What are the forecasts/targets for the OR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 386.5 | 0% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 408.4 | 5.7% |
OR Fundamental Data Overview
Market Cap EUR = 197.10b (197.10b EUR * 1.0 EUR.EUR)
P/E Trailing = 32.3403
P/E Forward = 27.3224
P/S = 4.4959
P/B = 6.4399
P/EG = 4.0424
Beta = 0.852
Revenue TTM = 76.78b EUR
EBIT TTM = 15.59b EUR
EBITDA TTM = 18.35b EUR
Long Term Debt = 4.76b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.64b EUR (from shortTermDebt, last quarter)
Debt = 8.83b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.01b EUR (from netDebt column, last quarter)
Enterprise Value = 201.11b EUR (197.10b + Debt 8.83b - CCE 4.82b)
Interest Coverage Ratio = 27.45 (Ebit TTM 15.59b / Interest Expense TTM 568.0m)
FCF Yield = 4.67% (FCF TTM 9.39b / Enterprise Value 201.11b)
FCF Margin = 12.22% (FCF TTM 9.39b / Revenue TTM 76.78b)
Net Margin = 14.60% (Net Income TTM 11.21b / Revenue TTM 76.78b)
Gross Margin = 73.80% ((Revenue TTM 76.78b - Cost of Revenue TTM 20.11b) / Revenue TTM)
Gross Margin QoQ = 74.67% (prev 70.48%)
Tobins Q-Ratio = 3.68 (Enterprise Value 201.11b / Total Assets 54.60b)
Interest Expense / Debt = 2.05% (Interest Expense 181.0m / Debt 8.83b)
Taxrate = 28.47% (1.34b / 4.71b)
NOPAT = 11.15b (EBIT 15.59b * (1 - 28.47%))
Current Ratio = 1.19 (Total Current Assets 18.28b / Total Current Liabilities 15.40b)
Debt / Equity = 0.28 (Debt 8.83b / totalStockholderEquity, last quarter 31.18b)
Debt / EBITDA = 0.22 (Net Debt 4.01b / EBITDA 18.35b)
Debt / FCF = 0.43 (Net Debt 4.01b / FCF TTM 9.39b)
Total Stockholder Equity = 30.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.53% (Net Income 11.21b / Total Assets 54.60b)
RoE = 36.45% (Net Income TTM 11.21b / Total Stockholder Equity 30.75b)
RoCE = 43.91% (EBIT 15.59b / Capital Employed (Equity 30.75b + L.T.Debt 4.76b))
RoIC = 29.16% (NOPAT 11.15b / Invested Capital 38.25b)
WACC = 8.82% (E(197.10b)/V(205.93b) * Re(9.15%) + D(8.83b)/V(205.93b) * Rd(2.05%) * (1-Tc(0.28)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.14%
[DCF Debug] Terminal Value 77.82% ; FCFE base≈8.66b ; Y1≈10.61b ; Y5≈17.81b
Fair Price DCF = 464.0 (DCF Value 247.41b / Shares Outstanding 533.2m; 5y FCF grow 24.08% → 3.0% )
EPS Correlation: 11.60 | EPS CAGR: 7.62% | SUE: 0.0 | # QB: 0
Revenue Correlation: -13.75 | Revenue CAGR: 12.22% | SUE: 0.81 | # QB: 0